N J Birkbak Selected Research

Complementation Group I Fanconi Anemia

1/2018

Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N J Birkbak Research Topics

Disease

3	Neoplasms (Cancer) 01/2019 - 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Triple Negative Breast Neoplasms 01/2018
1	Complementation Group I Fanconi Anemia 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
1	SaltsIBA 01/2018
1	taxaneIBA 01/2018
1	Bloom syndrome proteinIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	PlatinumIBA 01/2018

Therapy/Procedure

3	Therapeutics 01/2019 - 05/2015
1	Immunotherapy 01/2019